| Literature DB >> 25561959 |
Davood Moshkani Farahani1, Abbas Tavallaie2, Ensieh Vahedi3, Peyman Rezaiemaram4, Zohreh Naderi1, Akram Talaie1.
Abstract
OBJECTIVE: Sleep complaints are common among Iranian chemically-injured veterans. The growing body of research has investigated (in) equalities between such subjective complaints and objective sleep records. Moreover, sleep complaints are associated with depressive symptoms. Depressive symptoms, also, have been frequently reported in chemically-injured veterans. Therefore, the purpose of this pilot study was to investigate the relationship between perceived sleep quality, polysomnographic measures and depressive symptoms in Iranian veterans with chemical injuries.Entities:
Keywords: depression; polysomnography; sleep measures; veterans
Year: 2014 PMID: 25561959 PMCID: PMC4277808
Source DB: PubMed Journal: Iran J Psychiatry ISSN: 1735-4587
Descriptive statistics of the sample (n = 35)
| Measures | Variables | Mean±SD |
|---|---|---|
| PSG | 1. age (years) | 46±7.21 |
| 2. Total Sleep Time (Min) | 328.6±56.91 | |
| 3. Sleep Onset Latency (Min) | 40.2±14.09 | |
| 4. Sleep Efficiency(%) | 68.5±8.63 | |
| 5. Number of Awakenings | 6.34±1.27 | |
| 6. Stage 1 (%) | 10.5±3.14 | |
| 7. Stage 2 (%) | 54.7±7.21 | |
| 8. Stages 3- 4 (%) | 15.2±4.01 | |
| 9. REM (%) | 19.6±3.84 | |
| PSQI Components | 10. Subjective Sleep Quality | 57±2.8.0 |
| 11. Sleep Latency | 0.76±2.03 | |
| 12. Sleep Duration | 0.71±1.1 | |
| 13. Habitual Sleep Efficiency | 1.03±0.58 | |
| 14. Sleep Disturbances | 0.98±2.67 | |
| 15. Use of Sleep Medications | 1.15±1.01 | |
| 16. Daytime Dysfunction | 1.33±1.24 | |
| 17. Total Score | 8.22±2.07 | |
| BDI-II | 18. Total Score | 19.06±4.73 |
Correlation coefficients between research variables
| Measures | Variables | TST( | SOL( | SE | NA | Stage 1 (%) | Stage 2 (%) | Stage 3-4 (%) | REM (%) | SSQ | SL | SD | HSE | Dis. | USM | DD | PSQ Total Score | BDI-IITotal Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PSG | TST ( | – | 0.09 | 0.02 | -0.11 | 0.07 | 0.03 | 0.08 | 0.08 | 0.04 | -0.13 | 0.06 | -0.06 | 0.16 | -0.05 | -0.14 | 0.09 | 0.11 |
| SOL ( | – | 0.10 | 0.07 | 0.02 | 0.06 | 0.04 | 0.15 | 0.12 | 0.09 | 0.11 | 0.07 | 0.12 | 0.16 | 0.09 | -0.13 | -0.26 | ||
| SE (%) | – | 0.04 | 0.10 | 0.04 | 0.05 | 0.03 | 0.28 | 0.04 | 0.02 | 0.33 | -0.05 | -0.11 | -0.42 | 0.23 | -0.06 | |||
| NA | – | 0.03 | 0.04 | 0.09 | 0.04 | -0.02 | 0.12 | 0.04 | 0.09 | 0.09 | 0.03 | 0.08 | -0.04 | 0.09 | ||||
| Stage 1 (%) | – | 0.08 | 0. 13 | 0.13 | 0.07 | -0.06 | 0.03 | 0.07 | 0.01 | 0.05 | 0.12 | 0.08 | 0.04 | |||||
| Stage 2 (%) | – | 0.02 | 0.03 | -0.06 | 0.03 | 0.08 | -0.04 | 0.13 | 0.11 | -0.05 | 0.03 | 0.03 | ||||||
| Stages 3- 4 (%) | – | 0.07 | -0.04 | 0.11 | 0.13 | 0.09 | -0.07 | 0.04 | 0.09 | -0.02 | -0.06 | |||||||
| REM (%) | – | 0.11 | -0.07 | 0.02 | 0.03 | 0.04 | -0.07 | 0.04 | -0.07 | 0.28 | ||||||||
| PSQI Components | SSQ | – | 0.15 | 0.11 | 0.09 | -0.07 | -0.14 | -0.16 | 0.24 | -0.41 | ||||||||
| SL | – | 0.12 | 0.14 | 0.13 | 0.17 | 0.12 | 0.32 | 0.34 | ||||||||||
| SD | – | 0.13 | -0.08 | -0.12 | 0.17 | 0.23 | -0.07 | |||||||||||
| HSE | – | 0.14 | -0.09 | 0.18 | 0.26 | -0.16 | ||||||||||||
| Dis. | – | 0.16 | 0.16 | 0.33 | 0.39 | |||||||||||||
| USM | – | 0.13 | 0.17 | 0.44 | ||||||||||||||
| DD | – | 0.28 | 0.38 | |||||||||||||||
| Total Score | – | - 0.36 | ||||||||||||||||
| BDI-II | Total Score | – | ||||||||||||||||
= P < 0/05;
= P < 0/01.
PSG = Polysomnography; TST = Total Sleep Time; SOL = Sleep Onset Latency; SE = Sleep Efficiency; NA = Number of Awakenings; REM, Rapid Eye Movement; PSQI, the Pittsburgh Sleep Quality Index, SSQ = Subjective Sleep Quality; SL = Sleep Latency; SD = Sleep Duration; HSE = Habitual Sleep Efficiency; Dis. = Sleep Disturbances; USM = Use of Sleep Medications; DD = Daytime Dysfunction; BDI-II, the Beck Depression Inventory-Second Edition